MedPage Today on MSN9 小时
FDA Approves Novel Treatment for UTIs
The FDA approved oral sulopenem etzadroxil and probenecid (Orlynvah) to treat uncomplicated urinary tract infections (uUTIs) ...
The U.S. Food and Drug Administration has approved Iterum Therapeutics' oral antibiotic to treat certain types of bacterial ...
Veterinarians should become familiar with new definitions and recommendations for managing urinary tract infections in dogs ...
Katie, a hairdresser by trade, said: "I had slight symptoms during the year but I put it down to a UTI. I had my anus and ...
根据制造商葛兰素史克的新闻稿,FDA 已接受首创口服抗生素吉泊汀的新药申请 (NDA)。该药物具有新颖的作用机制,旨在治疗患有无并发症尿路感染(UTI)的女性和青春期女孩。 吉泊汀的 NDA 已获得 FDA 的优先审查,PDUFA 日期为 2025 ...
A YOUNG woman who thought nothing of her urinary tract infection was later told she in fact had cancer and thought she might ...
The FDA granted Priority Review to gepotidacin for the treatment of female adults and adolescents with uncomplicated UTI.
Urinary tract infections are common, especially, though not exclusively, in women, and the risk generally increases with age.
A woman who thought she just had a UTI was diagnosed with a rare tissue cancer and had to have part of her vagina wall ...
Iterum Therapeutics (NASDAQ:ITRM) stock shot up 54% Friday after the company received FDA approval for its drug Orlynvah for ...
ORLYNVAH™ is the first oral penem approved for use in the U.S. and the second FDA-approved treatment for uUTIs in the past two decades--Company ...
“Nobody should have to present to an emergency department for treatment for an uncomplicated urinary tract infection.” The ...